FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281661418> ?p ?o ?g. }

• W4281661418 abstract "<sec> <title>BACKGROUND</title> More than 75% of patients with breast cancer treated with chemotherapy experience cognitive impairments (eg, memory and attention problems), commonly known as <i>chemo-brain</i>. Exercise, especially aerobic high-intensity interval training (HIIT), is associated with better cognitive function in healthy populations. However, clinical trials testing the impact of exercise interventions on chemotherapy-induced cognitive decline in patients with cancer are lacking, and the mechanisms through which exercise could improve cognitive function are unclear. </sec> <sec> <title>OBJECTIVE</title> The objective of the Improving Cognitive Function Through High-Intensity Interval Training in Breast Cancer Patients Undergoing Chemotherapy trial is to examine the effects of HIIT on cognitive function in patients with breast cancer undergoing chemotherapy. </sec> <sec> <title>METHODS</title> This 2-arm, single-center, pilot randomized controlled trial will randomize 50 patients with breast cancer undergoing chemotherapy to HIIT or attention control. The HIIT group will perform a supervised 16-week, thrice-weekly intervention, with each session including a 5-minute warm-up at 10% maximal power output (POmax), 10 sets of alternating 1-minute high-intensity (90% POmax) and 1-minute recovery (10% POmax) intervals, and a 5-minute cooldown (10% POmax). The attention control group will receive a stretching program with no exercise components and be asked to maintain their exercise levels for 16 weeks. The primary outcomes of the study are executive function and memory measured using the National Institutes of Health toolbox and resting-state connectivity and diffusion tensor imaging microstructure evaluated using magnetic resonance imaging. The secondary and tertiary outcomes include cardiorespiratory fitness, body composition, physical fitness, and psychosocial health. The study has been approved by the institutional review board of the Dana-Farber Cancer Institute (20-222). </sec> <sec> <title>RESULTS</title> The trial was funded in January 2019, with recruitment started in June 2021. As of May 2022, a total of 4 patients have consented and been randomized (n=2, 50% to exercise; n=1, 25% to control; and n=1, 25% nonrandomized). Trial completion is expected in January 2024. </sec> <sec> <title>CONCLUSIONS</title> This first-of-its-kind study incorporates a novel exercise intervention (ie, HIIT) and comprehensive cognitive measures. If positive, our findings will establish the pilot efficacy of HIIT on chemotherapy-induced cognitive function in patients with breast cancer, providing the foundation for future larger phase-II and phase-III trials to confirm the findings and potentially establish HIIT as a standard of care for women undergoing chemotherapy for breast cancer. </sec> <sec> <title>CLINICALTRIAL</title> ClinicalTrials.gov NCT04724499; https://clinicaltrials.gov/ct2/show/NCT04724499 </sec> <sec> <title>INTERNATIONAL REGISTERED REPORT</title> DERR1-10.2196/39740 </sec>" @default.
• W4281661418 created "2022-06-13" @default.
• W4281661418 creator A5000464906 @default.
• W4281661418 creator A5012802554 @default.
• W4281661418 creator A5034294856 @default.
• W4281661418 creator A5040573037 @default.
• W4281661418 creator A5040836604 @default.
• W4281661418 creator A5042227976 @default.
• W4281661418 creator A5058778398 @default.
• W4281661418 creator A5077058201 @default.
• W4281661418 creator A5086744800 @default.
• W4281661418 date "2022-05-20" @default.
• W4281661418 modified "2023-09-27" @default.
• W4281661418 title "Improving cognitive function through high-intensity interval training in breast cancer patients undergoing chemotherapy – the CLARITY Trial: A study design and protocol. (Preprint)" @default.
• W4281661418 cites W1513119608 @default.
• W4281661418 cites W1583631062 @default.
• W4281661418 cites W1687156024 @default.
• W4281661418 cites W1847137107 @default.
• W4281661418 cites W1970864872 @default.
• W4281661418 cites W1974742404 @default.
• W4281661418 cites W1979866949 @default.
• W4281661418 cites W1987476514 @default.
• W4281661418 cites W1991881145 @default.
• W4281661418 cites W1992983467 @default.
• W4281661418 cites W1996482741 @default.
• W4281661418 cites W2001038217 @default.
• W4281661418 cites W2008844534 @default.
• W4281661418 cites W2011197370 @default.
• W4281661418 cites W2011961123 @default.
• W4281661418 cites W2027585107 @default.
• W4281661418 cites W2030568262 @default.
• W4281661418 cites W2030594499 @default.
• W4281661418 cites W2032254014 @default.
• W4281661418 cites W2038080503 @default.
• W4281661418 cites W2045960345 @default.
• W4281661418 cites W2047262956 @default.
• W4281661418 cites W2052254431 @default.
• W4281661418 cites W2052554888 @default.
• W4281661418 cites W2070902454 @default.
• W4281661418 cites W2071046918 @default.
• W4281661418 cites W2071360251 @default.
• W4281661418 cites W2073924965 @default.
• W4281661418 cites W2074076764 @default.
• W4281661418 cites W2076579116 @default.
• W4281661418 cites W2083727929 @default.
• W4281661418 cites W2092254928 @default.
• W4281661418 cites W2095458854 @default.
• W4281661418 cites W2096273437 @default.
• W4281661418 cites W2098192159 @default.
• W4281661418 cites W2102391253 @default.
• W4281661418 cites W2116823839 @default.
• W4281661418 cites W2136651421 @default.
• W4281661418 cites W2147461659 @default.
• W4281661418 cites W2148645553 @default.
• W4281661418 cites W2151359789 @default.
• W4281661418 cites W2166758089 @default.
• W4281661418 cites W2168524506 @default.
• W4281661418 cites W2320179271 @default.
• W4281661418 cites W2331198201 @default.
• W4281661418 cites W2345993726 @default.
• W4281661418 cites W2399078090 @default.
• W4281661418 cites W2612105957 @default.
• W4281661418 cites W2621044226 @default.
• W4281661418 cites W2730111329 @default.
• W4281661418 cites W2750436552 @default.
• W4281661418 cites W2762771471 @default.
• W4281661418 cites W2768866966 @default.
• W4281661418 cites W2769880098 @default.
• W4281661418 cites W2774434691 @default.
• W4281661418 cites W2792267984 @default.
• W4281661418 cites W2799646050 @default.
• W4281661418 cites W2911009565 @default.
• W4281661418 cites W2912424629 @default.
• W4281661418 cites W2953984817 @default.
• W4281661418 cites W2956139542 @default.
• W4281661418 cites W2961003428 @default.
• W4281661418 cites W2995065313 @default.
• W4281661418 cites W2999417355 @default.
• W4281661418 cites W3002076683 @default.
• W4281661418 cites W3008227618 @default.
• W4281661418 cites W3012215509 @default.
• W4281661418 cites W3016940236 @default.
• W4281661418 cites W3091849666 @default.
• W4281661418 cites W3094911927 @default.
• W4281661418 cites W3096426788 @default.
• W4281661418 cites W3118170707 @default.
• W4281661418 cites W3129811575 @default.
• W4281661418 cites W3166362741 @default.
• W4281661418 cites W3194835444 @default.
• W4281661418 cites W4241159580 @default.
• W4281661418 cites W4249364890 @default.
• W4281661418 cites W4319293029 @default.
• W4281661418 doi "https://doi.org/10.2196/preprints.39740" @default.
• W4281661418 hasPublicationYear "2022" @default.
• W4281661418 type Work @default.
• W4281661418 citedByCount "0" @default.
• W4281661418 crossrefType "posted-content" @default.
• W4281661418 hasAuthorship W4281661418A5000464906 @default.
• W4281661418 hasAuthorship W4281661418A5012802554 @default.
• W4281661418 hasAuthorship W4281661418A5034294856 @default.

• next